UnitedHealth Shares Surge as Q2 Results Top Forecasts and Guidance Raised
Strong cost control and Optum performance drive recovery.
Strong cost control and Optum performance drive recovery.
UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.
Bank of America upgraded UNH to Buy, raising target to $450 as lower healthcare costs boost earnings outlook.
Berkshire bought a $2.6B stake in Delta again and also took a small new position in Macy’s while reshaping its portfolio in Q1 2026.
UnitedHealth Group beat expectations, raised outlook, cut costs, and grew steadily—showing a solid turnaround and boosting investor confidence.
CMS boosts 2027 Medicare payments 2.5%, giving insurers $13B+, keeping plans stable and seniors’ benefits solid. Stocks jump.